Colton A. Smith

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Cliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al. · Blood · 1998 · 1.1K citations

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Helen E. Heslop, Karen S. Slobod, Martin Pulé et al. · Blood · 2009 · 771 citations · Full text

Infusion of Cytotoxic T Cells for the Prevention and Treatment of Epstein-Barr Virus–Induced Lymphoma in Allogeneic Transplant Recipients

Cliona M. Rooney, Colton A. Smith, Catherine Y. Ng et al. · Blood · 1998 · 375 citations

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

Stephen Gottschalk, Catherine Y. Ng, M. Nogales Pérez. et al. · Blood · 2001 · 267 citations

Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3.

Colton A. Smith, D Rennick · Proceedings of the National Academy of Sciences · 1986 · 144 citations · Full text

Mast Cell Disorder, T-regulatory Cell, Immune Regulation +21